iCo Therapeutics to Present at BIO InvestorForum in San Francisco

Oct 17, 2005, 01:00 ET from iCo Therapeutics Inc.

    VANCOUVER, Oct. 17 /PRNewswire/ - iCo Therapeutics Inc. announced today
 that Andrew Rae, iCo's Chief Executive Officer, will present at the BIO
 InvestorForum to be held October 19-20th, 2005 in San Francisco, California.
 Approximately 190 public and venture-stage companies are slated to present at
 this conference which is being hosted by the Biotechnology Industry
     Mr. Rae's presentation will take place on October 20th, 2005 at
 12:20pm PST in the Sea Cliff room at the Palace Hotel in San Francisco. For
 more information about the conference, visit the BIO InvestorForum website at
     A live audio webcast of Mr. Rae's presentation will be available to all
 interested parties through a link posted on iCo's website at
     iCo seeks out and develops or modifies approved or near-approved
 therapies to treat a variety of conditions within isolated biological
 environments. Because the drugs have already been through extensive
 preclinical and clinical testing, and in some cases regulatory approval,
 development risk and time to commercialization is significantly decreased.
     iCo Therapeutics Inc. is an emerging, Vancouver-based biotechnology
 company focused on developing pre-existing drugs for a range of new conditions
 affecting isolated biological environments - areas such as the eye, spinal
 cord, or joints - where locally-administered application of these therapies
 would have minimal systemic distribution and fewer safety issues.
     For more information, visit the company website at:
     Business Development Contact:           Finance/Investor Contact:
     Dr. John Clement, CTO                   Mr. John Meekison, CFO
     778.688.0644                            604.602.9414
     Media Contact:
     Elayne Wandler, ABCommunications

SOURCE iCo Therapeutics Inc.